PATENT CLAIM ANALYSIS

Application Number: 15774763
Application Type: Utility
Filing Date: 2018-05
Publication Date: 2018-12
Patent Classification: ["514", "013500"]

Abstract:
A method of reducing a cerebral tissue pathology associated with a sickle cell disease therapy in a subject is provided using (i) a synthetic high-oxygen affinity hemoglobin-containing molecule or (ii) synthetically treated high-oxygen affinity blood.

Claim (Index 5):
The method of  claim 1 , wherein the high-oxygen affinity blood has been ex vivo synthetically treated with 5-hydroxyl methyl furfural, hydroxyl urea, tucaresol (4-[(2-formyl-3-hydroxy-phenoxy)methyl]benzoic acid) or 2-hydroxy-6 ((2-(1-isopropyl-1H-pyrazol-5-yl) pyridin-3-yl) methoxy) benzaldehyde (\u201cGBT 440\u201d).

Metadata:
- Claim Count in Document: 1.0
- Percentile: 93.0
- Lexical Diversity: 1.21212
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['14454059', '13794978', '14451232', '14388956', '15764052']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7865917750965999
- 35 USC 102 Novelty (BERT): 0.5219391332432511
- Combined Prediction Score: 0.760126510911265
- Mean Citation Score: 280.047798
- Max Citation Score: 304.74384
- Similarity Product: 193.95699384487148

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test